Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

Galera Therapeutics, Inc., a clinical-stage drug discovery company, whose research and development is based in St. Louis, has announced that it has secured $150...

St. Louis Has “Agglomeration” In AgTech, According To A Brookings Report, And That’s A...

The Brookings Institution, a nonprofit public policy think tank based in Washington, DC released a report on July 25 (2018) entitled “Rethinking Cluster Initiatives”...

Latest Stories

Popular Stories